Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
about
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumorsInhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.Antiproliferative effect of chrysin on anaplastic thyroid cancerThe North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancerNeuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathwaysChrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivoTumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.New perspectives on the treatment of differentiated thyroid cancer.Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsCurrent understanding and management of medullary thyroid cancer.The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer.AKT and PTEN expression in human gastrointestinal carcinoid tumors.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways.Deltonin, a steroidal saponin, inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis and antiangiogenesis.Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth.Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.[The study of PI3K/AKT pathway in lung cancer metastasis and drug resistance].
P2860
Q33776640-E30BBDF4-F888-4D70-98F9-F5E8F1DFC53EQ34048712-5FB00812-A362-4B9A-8371-BBD31CDEA3ACQ34939579-C93A5A64-D9E8-4991-8433-DE8BDCB41E87Q35159092-0251CEDB-E666-46D9-B511-811F7DBAC3F6Q36164034-DA0D40D1-E260-4387-AFB4-0F609283DD5BQ36334183-FE98B490-2B3B-4897-86CA-B955A9BB25C9Q36484505-0C7E32CD-78EA-469B-A4F8-513157E1AB0AQ36790872-EA01BF61-9696-4ACF-AEA5-F6AFD81F9C26Q36904500-8C43FDB7-B17C-4F8A-9FD8-9A8932B83CCFQ37179117-74132A6A-1CE1-4EAD-938E-4269277BB498Q37247181-4F6D2B19-35CA-44C5-BFC5-ABDBC65967CEQ37350245-567AC46F-E27B-4BBD-AF16-9D3F1A48874CQ37418940-4073F9B1-2BF3-4A50-95D1-91F931A18045Q37985518-8AF87605-3B53-4769-A397-9381F9F633C9Q38239229-541BB000-0968-4CA2-AAF5-55A3000D1411Q38287178-4B2DC258-50C6-47A3-B93E-FEBA41FCC8C5Q39034721-BF8796CA-0898-4F9B-B42F-258CFCEB82FDQ39042894-0F237CC9-8F14-488B-B599-EDAC68352EDFQ39130053-AB156FFC-AD19-441D-BBB6-664E2CD182EBQ39208774-099D0854-24D0-4F72-A203-9CF64427305BQ39562925-F2B53261-DD85-454F-AF07-FBE6709EEDC4Q39616057-9871C4C8-5AF8-467F-A606-96986F00B550Q39747646-F4246F34-19B9-4E63-80A5-A62705DEEF4BQ39817600-C231A284-53C0-4B3B-AD75-C0BF764A6948Q41251561-A7DDC3A2-48E5-4867-98EE-2E99A2995A3EQ47907310-811A8E31-0B48-4B49-8D5C-FA33C37EB9E9Q53734974-37677CB8-BF3B-43F5-95CC-9509B2C94DA8Q54566371-166A4145-3937-4451-A33A-07A05D51C6F1
P2860
Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Apoptosis-mediated medullary t ...... y the PI3K inhibitor LY294002.
@en
type
label
Apoptosis-mediated medullary t ...... y the PI3K inhibitor LY294002.
@en
prefLabel
Apoptosis-mediated medullary t ...... y the PI3K inhibitor LY294002.
@en
P2093
P1433
P1476
Apoptosis-mediated medullary t ...... y the PI3K inhibitor LY294002.
@en
P2093
Herbert Chen
Mary Ndiaye
Muthusamy Kunnimalaiyaan
P304
1009-14; discussion 1014-5
P356
10.1016/J.SURG.2006.06.040
P407
P577
2006-11-01T00:00:00Z